Clinical Trials Logo

Clinical Trial Summary

Objectives:

1. Determine the surveillance practice patterns following curative resection of colorectal cancer

2. Identify patient characteristics related to eligibility for treatment after the detection of a colorectal cancer recurrence


Clinical Trial Description

A survey related to surveillance practice patterns following curative resection of colorectal cancer patients will be administered to eligible providers for them to complete. The survey collects basic information related to a providers' role in in colorectal care in addition to their perspective on patient characteristics that may directly influence a patients' ability to receive treatment for a recurrent colorectal cancer.

The surveys may be self-administered and completed anonymously, either in a hard copy or electronic formats. They may also be administered by the research personnel in a group setting for paper or electronic surveying. The surveys may be sent to providers as in PDF form for respondents to print and complete, handed out in person, emailed as a qualtrics study or electronically administered at a regularly occurring conference for colorectal cancer physicians. In the case the survey is electronically administered in a group setting, audience response equipment will be used. Individual data will be collected using electronic response devices. No personally identifying information will be collected. Participants will not be identifiable using data collected in these group settings. If the form is handed out in person, it will be given out and collected using a blank envelope to eliminate any way of identifying the provider completing it.

If respondents print and complete paper forms they will be ask to return them with no identifying information. Participants will be asked to place the deidentified survey in a sealed envelope and return through mail or in a drop-box placed in a common location, all envelopes returned to the study staff in person will be collected together and opened in aggregate. Electronically administered questionnaires, using audience response or a qualtrics survey, will have no identifying information. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02321488
Study type Observational
Source M.D. Anderson Cancer Center
Contact George Chang, MD, MS
Phone 713-792-6940
Status Recruiting
Phase N/A
Start date December 2014

See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A